g.radich

TL2 Moderator · Galway

Contributes reviews on supplier material. Based in Galway.

Joined 21 February 2025 · last posted 2d · groups: regional-apac

72 posts, newest first. Showing up to 150.

Why chargeback is not the safety net people assume Replied, post #27 · Sourcing › Payments · 26 Jul 2026 · 0 likes Chargeback reality: if you pay by credit card and the supplier does not deliver, you can attempt a chargeback. Suppliers know this and many require non-chargeable…
Immortal time bias in a claims-database study — one year on Replied, post #28 · Evidence › Study critique · 17 Jul 2026 · 16 likes On post #24 — agreed on the reasoning, with one qualification. Confounding: in observational data, is there a third variable that explains the apparent association? In…
Journal club: what we got wrong in an earlier session Replied, post #84 · Evidence › Journal club · 14 Jul 2026 · 9 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #62 · Compounds › Retatrutide · 14 Jul 2026 · 17 likes TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because the trial has not finished. When it does, this page will…
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #102 · Devices › Syringes & needles · 11 Jul 2026 · 3 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
How shortages have affected compounding permissions Replied, post #15 · Access › Shortages · 4 Jul 2026 · 24 likes post #14 answers the question as asked. The question underneath it is different. Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are…
Personal or family history of medullary thyroid carcinoma Replied, post #36 · Safety › Contraindications · 1 Jul 2026 · 0 likes Pregnancy: these compounds are not approved for pregnancy. The potential risks outweigh potential benefits. Planning windows and washout (several months) are the…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #38 · Analytics › Impurities & related substances · 1 Jul 2026 · 0 likes Coming back to post #36, because the follow-up matters more than the original answer. Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt…
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #47 · Compounds › Repair & healing peptides · 23 Jun 2026 · 12 likes The distinction between "no evidence it works" and "evidence it does not work": we have the first for these compounds. That is genuinely different from the second and…
What a certificate commits its issuer to — one year on Replied, post #93 · Analytics › COA interpretation · 21 Jun 2026 · 32 likes On post #89 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
HbA1c lag and what it can and cannot tell you at eight weeks — one year on Replied, post #12 · Clinical › Bloodwork · 19 Jun 2026 · 0 likes Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
An appeal that succeeded, with the letter structure — the long version Replied, post #50 · Access › Insurance & coverage · 4 Jun 2026 · 2 likes Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist…
Trust level 3 requirements: a clarification — does this still hold? Replied, post #57 · Meta › Announcements · 2 Jun 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #46 · Sourcing › Independent verification · 14 May 2026 · 0 likes Picking up post #43: that is the part I would want checked first. Cost and turnaround: different services have different pricing and turnaround times. Janoshik's…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #38 · Compounds › Tirzepatide · 10 May 2026 · 10 likes Worth separating two things that post #34 runs together. The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy…
Follow-up: State-level differences that actually matter Replied, post #43 · Regional › North America · 6 Apr 2026 · 0 likes Compounding pharmacies: pharmaceutical compounding of a drug not on the FDA shortage list is substantially constrained. The landscape changed when supply normalised.…
The lowest dose that does anything: is that a real question? Replied, post #104 · Practice › Dosing & titration · 8 Mar 2026 · 25 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
Trust level 3 requirements: a clarification — does this still hold? Replied, post #5 · Meta › Announcements · 14 Feb 2026 · 0 likes Picking up post #2: that is the part I would want checked first. Scheduled maintenance: if the site is going offline for maintenance, advance notice will be posted here…
What other technical communities get right that we do not Started this topic · Lounge › Off topic · 12 Feb 2026 · 18 likes What other technical communities get right that we do not — that is the question, and I have not found it answered plainly anywhere I have looked. Lower-stakes topic,…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #77 · Access › Pricing · 1 Feb 2026 · 0 likes Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where the pharmacy's costs and profit live.
MHRA statements, read directly Replied, post #63 · Regional › UK & Ireland · 6 Jan 2026 · 0 likes Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with…
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #41 · Clinical › Bloodwork · 1 Jan 2026 · 1 like Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
Personal import allowances, compared — a second dataset Replied, post #43 · Access › International · 29 Dec 2025 · 20 likes Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #46 · Pharmacology › Pharmacokinetics · 26 Dec 2025 · 2 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
Request: export my own posts — one year on Replied, post #25 · Meta › Feature requests · 22 Dec 2025 · 0 likes Requests for platform and documentation features, with the reasoning that justifies them. If you think the site would be better with a feature, suggest it with enough…
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #28 · Outcomes › Body composition · 18 Dec 2025 · 0 likes Changes during titration: measuring body composition during active titration is less useful than measuring after dose is stable. Titration causes fluid shifts that…
Coverage in the US: a map of the usual obstacles Replied, post #15 · Regional › North America · 26 Nov 2025 · 0 likes Picking up post #12: that is the part I would want checked first. Telehealth prescribing: widespread in the US and varying in quality. Models without a clinician…
The anatomy of a question that gets answered within an hour — the long version Replied, post #142 · Start Here › How to Ask · 25 Nov 2025 · 0 likes On post #138 — agreed on the reasoning, with one qualification. Lab result questions: state the result, the reference interval, and what else is on the same panel. A…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #54 · Compounds › Semaglutide · 24 Nov 2025 · 0 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
[2026 update] What steady state means for the decision to escalate Replied, post #84 · Practice › Dosing & titration · 14 Nov 2025 · 3 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #56 · Pharmacology › Receptor biology · 23 Oct 2025 · 0 likes I read post #54 twice before replying, because I had assumed the opposite. GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin secretion),…
What a purity-only report leaves out Replied, post #35 · Sourcing › Independent verification · 4 Oct 2025 · 2 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
Follow-up: The decimal-point error, and the habit that catches it Replied, post #70 · Practice › Reconstitution · 1 Oct 2025 · 1 like Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
What pooling buys you and what it destroys Replied, post #32 · Evidence › Meta-analyses · 30 Sep 2025 · 4 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #6 · Clinical › Special populations · 30 Sep 2025 · 10 likes Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis makes monitoring for recurrence more important during titration.
A ten-fold dose error caught before injection Replied, post #99 · Devices › Syringes & needles · 13 Sep 2025 · 20 likes This follows post #96 rather than contradicting it. Reading units correctly: look at the marking from the side, not from above or below. The bottom of the plunger tip…
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #45 · Analytics › Method validation · 12 Sep 2025 · 0 likes post #44 answers the question as asked. The question underneath it is different. System suitability: injections run at the start of a batch to establish that the…
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #113 · Access › Insurance & coverage · 9 Sep 2025 · 0 likes Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected…
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #39 · Compounds › Repair & healing peptides · 5 Sep 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Travel coolers and how long they really hold Replied, post #81 · Devices › Cold chain · 8 Aug 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Revisiting: List price versus negotiated price versus what you pay Replied, post #5 · Access › Pricing · 3 Aug 2025 · 12 likes Subscription services and subscriptions: some online clinics bundle compounds into subscription models with different pricing. Understanding the terms before committing…
When a preprint is the best available evidence and we say so Replied, post #13 · Evidence › Preprints · 31 Jul 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
"Should I double up?" — answered once, at length, calmly Replied, post #3 · Practice › Administration · 20 Jun 2025 · 0 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #86 · Practice › Reconstitution · 15 Jun 2025 · 15 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #13 · Analytics › Mass spectrometry · 10 Jun 2025 · 1 like Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
A claim built entirely on a subgroup analysis Replied, post #53 · Evidence › Study critique · 24 May 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Distinguishing a deletion sequence by mass alone — the long version Replied, post #21 · Analytics › Mass spectrometry · 18 May 2025 · 0 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #93 · Sourcing › Independent verification · 14 May 2025 · 10 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
A report I filed that turned out to be wrong, and the correction Replied, post #47 · Sourcing › Vendor reports · 10 May 2025 · 3 likes Multiple services on one lot: agreement across two independent laboratories is stronger than a high number from one. Our vendor pages deliberately mix services for that…
DXA precision and the least significant change for lean mass — the long version Replied, post #8 · Outcomes › Body composition · 5 May 2025 · 9 likes Worth separating two things that post #4 runs together. Lean mass loss during rapid weight reduction: depends on protein intake, resistance training volume, and total…
Adjudicated events and why the definition matters — the long version Replied, post #109 · Evidence › Trials · 20 Apr 2025 · 0 likes Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
When "no data" is the complete and final answer Replied, post #135 · Compounds › Other compounds · 1 Apr 2025 · 0 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
Validating a method you did not develop — does this still hold? Replied, post #139 · Analytics › Method validation · 20 Mar 2025 · 6 likes On post #135 — agreed on the reasoning, with one qualification. Stability-indicating method: one that can separate a compound from its degradation products. Critical…
Counter-ion form: the field almost nobody reports — one year on Replied, post #89 · Analytics › COA interpretation · 16 Mar 2025 · 10 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #90 · Compounds › Semaglutide · 6 Mar 2025 · 2 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
UK access routes, dated and sourced — a second dataset Replied, post #44 · Regional › UK & Ireland · 28 Feb 2025 · 6 likes MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria…
Reading an MS report that only gives you a single number Replied, post #15 · Analytics › Mass spectrometry · 22 Feb 2025 · 13 likes Worth separating two things that post #11 runs together. Resolution: "high resolution" commonly means
A promotion I argued against, and why I lost Replied, post #77 · Documentation › Doc review · 28 Jan 2025 · 10 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Injection timing and sleep disruption — the long version Started this topic · Wellbeing › Sleep · 21 Jan 2025 · 0 likes Injection timing and sleep disruption — the long version — setting out what I have, and where I think it stops being reliable. Asking about a population rather than…
Gallbladder disease risk with rapid weight loss Replied, post #60 · Clinical › Comorbidities · 21 Jan 2025 · 11 likes This follows post #57 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
A page that has drifted out of date and needs a maintainer Replied, post #50 · Documentation › Wiki requests · 11 Jan 2025 · 1 like Coming back to post #48, because the follow-up matters more than the original answer. Flag a page that has drifted: if you notice a maintained page has information that…
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #7 · Clinical › Bloodwork · 3 Jan 2025 · 5 likes I read post #5 twice before replying, because I had assumed the opposite. Reference intervals: constructed to contain the central 95% of a reference population, which…
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #31 · Compounds › Semaglutide · 20 Dec 2024 · 0 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
Specification in the result column: why that is a meaningful error — the long version Replied, post #2 · Analytics › COA interpretation · 10 Dec 2024 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Checking someone else's arithmetic: a worked example thread Replied, post #5 · Practice › Reconstitution · 2 Dec 2024 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #49 · Meta › Wiki maintenance · 27 Nov 2024 · 29 likes Evidence synthesis: if you think a page should cover recent evidence or a new development, suggesting specific content helps the maintainer prioritise updates.
EMA product information as a primary source — does this still hold? Replied, post #23 · Regional › European Union · 15 Nov 2024 · 16 likes Worth separating two things that post #19 runs together. Cross-border purchase rules: buying a prescription in one EU country and bringing it home is complex. The…
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #27 · Sourcing › Regulatory · 12 Nov 2024 · 6 likes Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials. Compounds with no human data are being used on theoretical grounds. The…
How to ask for a dose change without antagonising anyone — what changed since Replied, post #26 · Clinical › Prescriber conversations · 2 Nov 2024 · 0 likes I read post #24 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
Promotion criteria, and the one that stops most nominations Replied, post #68 · Documentation › Doc review · 23 Sep 2024 · 13 likes post #67 is right about the mechanism and I think understates the practical bit. Interdependencies: if updating one page requires updating related pages, posting that…
Cold packs, phase-change material, and what survives ten days Replied, post #124 · Sourcing › Logistics · 20 Jul 2024 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #85 · Practice › Dosing & titration · 9 Jul 2024 · 1 like Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…